The Quantellect read.As of Nov 19, 2026, 3 active firms cover Aspen Aerogels Inc: 2 rate it Buy or better, 0 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets range widely, $3.00 to $6.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $4.67 sits 5% below the current $4.91. The rating mix has stayed broadly stable, with Buy-side ratings easing from 3 to 2 over recent months. On the fundamentals, the Street sees revenue growth near -32% this year and 48% next, consensus EPS building from about $-0.03 next quarter toward $0.02 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Neutral
Strong Buy00%
Buy267%
Neutral00%
Sell133%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$4.67
-4.9% downside
Average target across 3 active firms as of Nov 19, 2026 vs $4.91 current
Highest Target$6.00
Average Target$4.67
Lowest Target$3.00
Detailed analyst forecasts for ASPN
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 2 of 3 active firms rate ASPN a Buy (0 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ASPN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.03
Range $-0.10 – $0.06 · 3 analysts · -89% YoY
Next period, 3 analysts expect Aspen Aerogels Inc to earn $-0.03 a share (range $-0.10 – $0.06), versus $-0.28 a year earlier. Full-year consensus is $-0.27, growing to $0.02 the year after.
REVENUE · NEXT QUARTER
$61.1M
Range $52.6M – $75.6M · 3 analysts · -47% YoY
Revenue is expected to reach $61.1M (range $52.6M – $75.6M), -47.0% year-over-year. Full-year consensus is $239.6M, rising to $283.9M next year.
Top analysts covering Aspen Aerogels Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ASPN.
#1
Eric Stine
Craig-Hallum · Rank #166
Buy
$18.00+267.0% to target
Overall win rate
44%
+ Follow
#2
David Anderson
Barclays · Rank #190
Sell
$5.00+1.9% to target
Overall win rate
48%
+ Follow
#3
Colin Rusch
Oppenheimer · Rank #261
Neutral
No targeton ASPN
Overall win rate
37%
+ Follow
#4
Chip Moore
Roth MKM · Rank #403
Buy
$3.00-38.8% to target
Overall win rate
30%
+ Follow
#5
George Gianarikas
Canaccord Genuity · Rank #430
Buy
$5.00+1.9% to target
Overall win rate
34%
+ Follow
ASPN stock forecast FAQ
What is ASPN's average 12-month price target?+
The 3 active firms with a live target average $4.67 for Aspen Aerogels Inc over the next 12 months, ranging from a $6.00 high to a $3.00 low, as of Nov 19, 2026.
Is ASPN stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 3 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 0 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ASPN?+
The Street-high target is $6.00 (TD Cowen), and the Street-low is $3.00 (Roth Capital). The average of all 3 active-firm targets is $4.67.
How many active Wall Street firms cover ASPN?+
3 active firms have a recognized rating on Aspen Aerogels Inc as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ASPN?+
Among analysts who currently cover ASPN, Eric Stine of Craig-Hallum has the strongest overall Quantellect track record (Rank #166). Their current call is Buy with a $18.00 target.
What is Aspen Aerogels Inc's projected EPS for next quarter?+
The consensus estimate is $-0.03 per share (range $-0.10 – $0.06) across 3 analysts. Full-year EPS is projected at $-0.27, rising to $0.02 the following year.
How much revenue is Aspen Aerogels Inc expected to report next quarter?+
Consensus revenue is $61.1M (range $52.6M – $75.6M). Full-year revenue is projected at $239.6M, growing to $283.9M next year.
Have analysts been upgrading or downgrading ASPN lately?+
As of Nov 19, 2026, 2 of 3 active firms rate ASPN a Buy (0 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ASPN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.